Search Orphan Drug Designations and Approvals
-
Generic Name: | belimumab |
---|---|
Date Designated: | 01/24/2023 |
Orphan Designation: | Treatment of systemic sclerosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
GSK LLC 2929 Walnut St, Suite 1700 Philadelphia, Pennsylvania 19112 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-